COVID-19 Report
We’ve rounded up some of the latest news and announcements pertaining to the coronavirus and the healthcare industry.
Read MoreThe Incrementalist
See One Virtually
New On Demand Dr. Nick: The Incrementalist: With guest Sandra Humbles, VP of the Global Education Solutions Group at Johnson and Johnson Institute. The institute has been working on educational tools and solutions for clinicians that are using technology to augment and accelerate learning.
Integrating Patient Data
New On Demand Dr. Nick: The Incrementalist: With guest Lucie Ide, MD, PhD, founder of Rimidi, one of HIMSS’ Most Influential Women in Health IT, and one of Healthcare Global’s Top 10 Influential Women in Healthcare Technology.
COVID-19 Report
We’ve rounded up some of the latest news and announcements pertaining to the coronavirus and the healthcare industry.
Friday at Five: Celebrating The Incrementalist
To commemorate HealthcareNOW Radio’s show The Incrementalist crossing the milestone of 100 episodes, this week’s Friday at Five celebrates the show and its host, Dr. Nick.
Friday at Five – Top On Demand Episodes
This week’s Friday at Five lists the most played podcast episodes and the most played radio episodes on HealthcareNOW Radio’s SoundCloud channel within the last three months including timely episodes about the COVID-19 pandemic, the race for a vaccine, all things telehealth and so much more.
Sorting out AI, ML, DL, and NLP
This is our ongoing reporting on how AI is being integrated into healthcare technology. We are seeking out the thought leaders and innovations that are moving the needle forward which include Olive, GE Healthcare, Saykara, Nephrology Associates, Viz.ai, Endpoint Health, BUDDI.AI, & Vanderbilt University Medical Center.
COVID-19 Report
We’ve rounded up some of the latest news and announcements pertaining to the coronavirus and the healthcare industry.
Pandemic Security
New On Demand Dr. Nick: The Incrementalist: With guest Dr. Jake Reder, PhD the CEO of CeldaraMedical – an innovation incubator and accelerator focused on transforming academic innovations into medicines that cure the world’s most challenging diseases.